Fully-compliant chemical factory for sale

15 December 2008

Savills, for its client Henkel Ltd, has brought to the market a fully functional and licensed chemical mixing factory at the Belvedere Industrial Estate in Kent, UK, for a guide price of L3.5 million ($5.2 million).

The freehold complex, owned and formerly occupied by Henkel, comprises a factory of around 54,000 sq ft (5,016 sq m) on a 5.5 acres (2.2 hectares) site. There are three units, which include warehousing, production and maintenance facilities, as well as a self-contained office building totalling 6,000 sq ft (557 sq m). The production areas are all fully-fitted with holding tanks and a computerized mixing system, which the purchaser can retain. Henkel will begin decommissioning in January 2009.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight